SCHEMBL2052653

SCHEMBL2052653

CCOC(=O)CN(C(=O)OC(C)(C)C)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
GAA P10253 2/20 0.39
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
ALDH1A1 P00352 4/20 0.36
TRPA1 O75762 1/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
HDAC6 Q9UBN7 2/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC2 Q92769 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7719332 0.84 GAA (0.45) CA12CA1CA2CA9GAA
SCHEMBL646025 0.81 CA14 (0.38) CA12CA1CA2GAAMGAM
SCHEMBL18758783 0.81 CA12 (0.43) CA12CA1CA2CA9GAA
SCHEMBL5001089 0.80 CA12 (0.55) CA12CA1CA2CA9GAA
SCHEMBL1760327 0.79 CA12 (0.41) CA12CA1CA2CA9GAA
SCHEMBL7204430 0.79 CA12 (0.41) CA12CA1CA2CA9GAA
SCHEMBL22216177 0.78 GAA (0.52) CA12CA1CA2CA9GAA
SCHEMBL14088913 0.77 CA12 (0.40) CA12CA1CA2CA9GAA
SCHEMBL12498231 0.77 CA12 (0.40) CA12CA1CA2CA9GAA
SCHEMBL52467 0.77 HDAC6 (0.40) GAACYP2C19HDAC6HDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075699-A2 COMPOUNDS FOR TREATING DISORDERS MEDIATED BY METABOTROPIC GLUTAMATE RECEPTOR 5, AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2011-06-23 WO disclosed